ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,007.19
      -1.27%
      US Tech 100
      16,800.20
      -1.53%
      Dow Jones
      37,850.50
      -1.59%
      Brent Oil
      86.68
      -0.62%
      Bitcoin
      63,565.04
      -1.11%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Amarin Corp PLC (AMRN)

      7. Amarin Corp PLC (AMRN) News

      AMRN Amarin Corp PLC

      0.8657
      -0.0129 (-1.47%)
      Last Updated: 11:05:35
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Amarin Corp PLC AMRN NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.0129 -1.47% 0.8657 11:05:35
      Open Price Low Price High Price Close Price Prev Close
      0.88 0.8655 0.8899 0.8786
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      4/24/202414:00GLOBEAmarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA..
      4/22/202408:00GLOBEAmarin Announces Results of Annual General Meeting of..
      4/15/202408:00GLOBEAmarin to Report First Quarter 2024 Financial Results and..
      4/08/202408:00GLOBEAmarin Highlights Key Data Providing Mechanistic Insights..
      4/08/202406:30PRNCANew REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl)..
      4/06/202415:30GLOBENew REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent..
      4/03/202408:00GLOBEAmarin Provides Update on VAZKEPA® (Icosapent Ethyl)..
      3/25/202408:00GLOBEResearch Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent..
      3/04/202417:30EDGAR2Form ARS - Annual Report to Security Holders
      3/04/202408:00EDGAR2Form DEF 14A - Other definitive proxy statements
      2/29/202407:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/29/202407:05EDGAR2Form 8-K - Current report
      2/29/202407:00GLOBEAmarin Reports Fourth Quarter and Full Year 2023 Financial..
      2/15/202408:00GLOBEAmarin to Report Fourth Quarter and Full Year 2023 Financial..
      2/12/202408:00EDGAR2Form PRE 14A - Other preliminary proxy statements
      2/09/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/09/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/02/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/26/202407:00EDGAR2Form 8-K - Current report
      1/24/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202407:30GLOBEAmarin Chairman & CEO Issue Letter to Shareholders
      1/12/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/12/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/12/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/10/202407:00EDGAR2Form 8-K - Current report
      1/10/202407:00GLOBEAmarin Provides Preliminary Fourth Quarter 2023 Selected..
      1/08/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/08/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/02/202416:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/14/202318:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202316:20EDGAR2Form 144 - Report of proposed sale of securities
      12/11/202308:00GLOBEAmarin to Present at the 42nd Annual J.P. Morgan Healthcare..
      12/05/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/05/202307:30EDGAR2Form SC 13D/A - General statement of acquisition of..
      11/12/202309:00GLOBENew REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl)..
      11/03/202316:30EDGAR2Form 8-K - Current report
      11/01/202307:05EDGAR2Form 8-K - Current report
      11/01/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/01/202307:00GLOBEAmarin Reports Third Quarter 2023 Financial Results
      10/31/202316:05EDGAR2Form 8-K - Current report
      10/31/202312:00GLOBEAmarin Appoints Jonathan Provoost Executive Vice President,..
      10/26/202308:00GLOBELatest Research Evaluating VASCEPA®/VAZKEPA® (icosapent..
      10/19/202308:00GLOBE Amarin to Report Third Quarter 2023 Financial Results and..
      9/12/202308:00GLOBEAmarin to Present at the 2023 Cantor Global Healthcare..
      9/05/202316:15EDGAR2Form SC 13D/A - General statement of acquisition of..
      8/16/202319:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      AMRN
      Amarin
      Delayed Upgrade Clock